Encompass Health Corporation Common Stock (EHC) — Analysis Summary
Encompass Health Corporation Common Stock (EHC) has a market cap of $10.92B with year-over-year revenue growth of +10.5%. Net margin stands at 9.5%. The stock trades at a P/E ratio of 17.9.
Key Takeaways
- Revenue changed +10.5% year-over-year
- Net margin of 9.5%
- P/E ratio of 17.9
Compared to other companies in the SERVICES-HOSPITALS sector, EHC posted revenue growth of +10.5% and trades at a P/E of 17.9.
Encompass Health Corporation Common Stock (EHC)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Operating margin (9.8%) exceeds gross margin (0.0%) — check for other operating income or data classification issues
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Sector
SERVICES-HOSPITALS
Employees
29,944
Headquarters
BIRMINGHAM, AL
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$0.76
Dividend Yield
0.70%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.